04/22/2024 4:06 PM | Soleno Therapeutics (Filer)
| Form ARS | |
04/22/2024 3:31 PM | Soleno Therapeutics (Filer)
| Form DEF 14A | |
04/22/2024 3:15 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
04/03/2024 8:36 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:37 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:39 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
04/03/2024 8:40 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
|
03/07/2024 5:06 AM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/13/2024 4:35 PM | JANUS HENDERSON GROUP PLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G/A | |
02/07/2024 7:01 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G/A | |
01/30/2024 3:57 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/29/2024 4:42 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:44 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/29/2024 4:47 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/10/2024 3:31 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:34 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:35 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:36 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/08/2024 4:37 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/05/2024 3:16 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/15/2023 5:00 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 6:57 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 4:09 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 8:32 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:32 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:34 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 8:34 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/13/2023 3:46 PM | Soleno Therapeutics (Subject) Yen Kristen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 3:53 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 5:17 PM | Soleno Therapeutics (Subject) Yen Kristen (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 6:05 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 6:21 PM | Mackaness James H (Reporting) Soleno Therapeutics (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/04/2023 7:41 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:02 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:03 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:04 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:06 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:50 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:51 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:52 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
11/30/2023 8:52 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
10/31/2023 11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
10/23/2023 3:20 PM | PERCEPTIVE ADVISORS LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/20/2023 3:32 PM | Soleno Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
10/16/2023 3:30 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
10/12/2023 3:30 PM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/12/2023 3:05 PM | COMMODORE CAPITAL LP (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/11/2023 3:30 PM | Soleno Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D/A | |
10/10/2023 3:30 PM | Fairmount Funds Management LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/06/2023 10:45 AM | JANUS HENDERSON GROUP PLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/05/2023 4:09 PM | RA CAPITAL MANAGEMENT, L.P. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13G | |
10/04/2023 3:30 PM | Soleno Therapeutics (Issuer) Vivo Opportunity Fund Holdings, L.P. (Reporting) Vivo Opportunity, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/04/2023 9:36 AM | Soleno Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
10/02/2023 6:54 PM | Abingworth Bioventures VII LP (Reporting) Abingworth LLP (Reporting) Carlyle Genesis UK LLC (Reporting) Carlyle Group Inc. (Reporting) Carlyle Group Inc. (Reporting) Carlyle Holdings I GP Inc. (Reporting) Carlyle Holdings I GP Sub L.L.C. (Reporting) Carlyle Holdings I L.P. (Reporting) Carlyle Investment Management LLC (Reporting) CG Subsidiary Holdings L.L.C. (Reporting) Soleno Therapeutics (Issuer) TC Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/29/2023 3:51 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/28/2023 8:51 PM | PERCEPTIVE ADVISORS LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
09/28/2023 4:00 PM | Soleno Therapeutics (Issuer) Vivo Opportunity Fund Holdings, L.P. (Reporting) Vivo Opportunity, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 2:45 PM | EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
09/28/2023 6:00 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/28/2023 6:02 AM | Soleno Therapeutics (Subject)
| Form FWP | |
09/27/2023 8:32 PM | Soleno Therapeutics (Filer)
| Form S-3MEF | |
09/27/2023 4:23 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
09/27/2023 4:26 PM | Soleno Therapeutics (Filer)
| Form 424B5 | |
09/26/2023 6:30 AM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/18/2023 3:15 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
08/16/2023 3:12 PM | Pauls Matthew (Reporting) Soleno Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
08/16/2023 3:13 PM | Pauls Matthew (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/16/2023 8:00 AM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2023 4:25 PM | Soleno Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
08/02/2023 11:15 PM | Soleno Therapeutics (Filer)
| Form EFFECT | |
07/21/2023 3:10 PM | Soleno Therapeutics (Filer)
| Form S-1 Registration statement under Securities Act of 1933 | |
07/10/2023 3:06 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/05/2023 7:13 PM | Soleno Therapeutics (Issuer) Volck Birgitte (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 4:41 PM | EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/01/2023 4:00 PM | Soleno Therapeutics (Subject) Vivo Opportunity Fund Holdings, L.P. (Filed by)
| Form SC 13D | |
05/30/2023 3:15 PM | PERCEPTIVE ADVISORS LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/26/2023 5:26 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:27 PM | Harris William G (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:28 PM | Hirano Patricia C (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:28 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:29 PM | MARIO ERNEST (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:30 PM | Melincoff Gwen A (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:30 PM | Sinclair Andrew (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 5:39 PM | Soleno Therapeutics (Issuer) Yen Kristen (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 4:57 PM | EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/26/2023 12:14 PM | SCHULER JACK W (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/23/2023 5:47 PM | EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/18/2023 3:31 PM | EDELMAN JOSEPH (Reporting) PERCEPTIVE ADVISORS LLC (Reporting) PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting) Soleno Therapeutics (Issuer)
| Form 3 Initial statement of beneficial ownership of securities | |
05/18/2023 3:32 PM | PERCEPTIVE ADVISORS LLC (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D | |
05/15/2023 3:04 PM | SCHULER JACK W (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2023 4:28 PM | Anish Bhatnagar (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
Better than Bitcoin? The Biotech Stock with 46,751% Potential (Ad) 4x Better than Bitcoin
Bitcoin would have to go from $68,000 to $314,000 to match the 463% gains we saw with Immunogen in December. Get the name of the stock here >>> |
05/10/2023 4:28 PM | Mackaness James H (Reporting) Soleno Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2023 3:30 PM | Abingworth LLP (Reporting) Carlyle Genesis UK LLC (Reporting) Carlyle Group Inc. (Reporting) Carlyle Group Inc. (Reporting) Carlyle Holdings I GP Inc. (Reporting) Carlyle Holdings I GP Sub L.L.C. (Reporting) Carlyle Holdings I L.P. (Reporting) Carlyle Investment Management LLC (Reporting) CG Subsidiary Holdings L.L.C. (Reporting) Soleno Therapeutics (Issuer) TC Group, LLC (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
05/10/2023 3:32 PM | Carlyle Group Inc. (Filed by) Carlyle Group Inc. (Filed by) Soleno Therapeutics (Subject)
| Form SC 13D/A | |
05/09/2023 3:31 PM | Soleno Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
05/03/2023 4:26 PM | Soleno Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |